Install
Master the Science of Success through aspirational coverage for executive-level decisions, leadership, management, strategy and commercialization professionals.
- 913articles · 365d
- 14+ hour agolatest article
- Sep 14, 2025earliest in window
- 95%with images
- 285avg words
- Medical 573
- Business & Industrial 538
- Economy, Business & Finance 451
- Health & Wellness 337
- Health 267
- Finance & Business 254
- Science & Technology 156
- Science & Nature 42
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Boards, AI, and 500 Years of Experience in Life Sciences: Takeaways from the 2026 Life Sciences Board Forum
14+ hour, 3+ min ago (92+ words) This June, ten of the life sciences industry’s most respected board members came to New York for Accenture’s second annual Life Sciences Board Forum for something this industr... Ten life sciences board directors on AI's three hardest questions: developing the…...
Unlocking the Future of Real-World Data & Research | PharmExec
4+ day, 2+ hour ago (40+ words) Unlocking the Future of Real-World Data & Research Pharmaceutical Executive Pharmaceutical Executive Daily: Moonwalk Biosciences' $70 Million Series B Trusted Research Environments Are Reshaping Real-World Data Access: Q&A with Mark Cziraky FDA Approves Zanvastro for Alexander Disease in Pediatrics & Adults...
Pharmaceutical Executive Daily: Moonwalk Biosciences' $70 Million Series B
4+ day, 12+ hour ago (83+ words) Moonwalk Biosciences' $70 Million Series B | PharmExec Pharmaceutical Executive Aptar Pharma and Aceso Therapeutics team up to advance an inhaled cystic fibrosis therapy, Moonwalk Biosciences raises a $70 million Series B for its fat-targeted obesity platform, and Sebastian Arana of MilliporeSigma talks…...
Why Global Science Innovation is Shifting to Asia | PharmExec
2+ week, 3+ day ago (57+ words) Why Global Science Innovation is Shifting to Asia Pharmaceutical Executive Pharmaceutical Executive Daily: FDA Approves Imaavy for wAIHA What Executives and Investors Are Looking for in Pharma Companies FDA Approves Imaavy for Warm Autoimmune Hemolytic Anemia in Patients Aged 12 and…...
What Executives and Investors Are Looking for in Pharma Companies
2+ week, 3+ day ago (258+ words) K2 Therapeutics CEO Ying Huang discusses the three priorities that define a successful biotech: unmet need, development cost, and accessible pricing. Earlier this year, Pharmaceutical Executive reported on China’s growing prominence in the pharma and biotech spaces. During this year, billions…...
M&A Roundup: Novo Nordisk Enters AI Drug Discovery Partnership with Amazon, Innate Pharma Partners with Sobi, Innovent Enters Commercialization Agreement with Daiichi Sankyo
1+ mon, 3+ day ago (273+ words) Novo Nordisk selects AWS as its preferred AI partner for drug discovery, Innate Pharma partners with Sobi, and Innovent Biologics secures exclusive commercialization rights for Vanflyta in China. A wave of new partnerships is overtaking the pharma sector and reshaping…...
Pharmaceutical Executive Daily: Bristol Myers Squibb Expands Partnership with Nvidia
1+ mon, 3+ week ago (533+ words) In today's Pharmaceutical Executive Daily, Invivyd's chief scientific officer discusses a platform designed to predict future viral variants ahead of time, Bristol Myers Squibb expands its AI compute infrastructure with Nvidia to build what it calls the most powerful AI…...
Bristol Myers Squibb Expands Collaboration with Nvidia to Build AI Factory
1+ mon, 3+ week ago (426+ words) Bristol Myers Squibb is deploying Nvidia's DGX SuperPOD with Vera Rubin NVL72 systems to build what it claims is the most powerful AI computing infrastructure in life sciences. Bristol Myers Squibb (BMS) announced an expansion of its compute infrastructure through the…...
What if patient onboarding evolved alongside today's therapies?
1+ mon, 3+ week ago (96+ words) Pharmaceutical Executive What if patient onboarding evolved alongside today's therapies? Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers. The Connected Patient Ecosystem Human Factors is more than a regulatory…...
Insilico Medicine Enters $2.5 Billion Alliance with Bora Pharmaceuticals
1+ mon, 4+ week ago (212+ words) Insilico Medicine and Bora Pharmaceuticals entered a strategic alliance to pair Insilico's AI drug discovery platform with Bora's development and manufacturing infrastructure. If fully implemented, the potential value of the proposed collaboration could exceed $2.5 billion, as the definitive agreements governing…...